Status:
COMPLETED
COVID-19 Testing and Vaccination Among Spanish Speakers
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
COVID-19
Vaccinations
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Latinx communities are disproportionately affected by the COVID-19 pandemic, with Spanish-speaking Latinx communities carrying even heavier burdens of infection, hospitalization, and mortality. Major ...
Detailed Description
A profound need remains to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing and vaccination interventions within Spanish-speaking Latinx communities. The proposal...
Eligibility Criteria
Inclusion
- To be eligible to participate in the in the NuestraSaludSegura intervention as a Navegante:
- participant must self-identify as Hispanic/Latinx
- participant must be Spanish speaking
- participant reports having been vaccinated against COVID-19
- participant must be ≥18 years of age
- participant must provide informed consent
- To be eligible to participate in the interviews as a Social Network Member:
- participant must self-identify as Hispanic/Latinx
- participant must be Spanish speaking
- participant must be ≥ 18 years of age
- participant must provide informed consent
Exclusion
- less than 18 years of age
Key Trial Info
Start Date :
February 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT05302908
Start Date
February 9 2023
End Date
November 30 2024
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157